Trials / Unknown
UnknownNCT00645723
Intravenous Colistin Versus Intravenous Colistin Plus Nebulized Colistin in VAP Due MDR Acinetobacter Baumannii
Phase 3b Randomized Double Blind Controled Placebo Comparative Trial of Intravenous Colistin vs Intravenous Colistin Plus Nebulized Colistin in Patients With Ventilator-associated Pneumonia (VAP) Due Multiresistant Acinetobacter Baumanii
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 67 (estimated)
- Sponsor
- Hospitales Universitarios Virgen del Rocío · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Compare the clinical efficiency evaluated by the treatment of the intravenous colistin plus inhaled colistin opposite to the treatment with colistin intravenous plus inhaled saline solution in patients with VAP due to baumannii carbapenems resistant.
Detailed description
Compare the clinical efficiency evaluated by the treatment of the intravenous colistin plus inhaled colistin opposite to the treatment with colistin intravenous plus inhaled saline solution in patients with VAP due to baumannii carbapenems resistant.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Colistin | intravenous colistin and nebulized colistin |
| DRUG | Colistin and saline solution | intravenous colistin and nebulized saline solution |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2011-04-01
- Completion
- 2011-04-01
- First posted
- 2008-03-28
- Last updated
- 2009-08-06
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT00645723. Inclusion in this directory is not an endorsement.